Top Tweets for #Trialsinprogress
SWI/SNF alterations may identify a subset of pancreatic cancers susceptible to immunotherapy #TrialsInProgress @JCOOA_ASCO @Dr_R_Kurzrock
https://t.co/CCV98Kdolz

#TrialsinProgress - The #GAIN trial (ALLIANCE A032303): Gemcitabine alternating with intravesical BCG randomization against BCG alone for patients with recurrent “BCG Exposed” high-grade #NMIBC. Presentation by @eugene_pietzak @MSKCancerCenter. #SUO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/rog7llKH1X @UroOnc #SUO2025

#TrialsinProgress - In-home iNtraVesIcal ThErapy (INVITE) Study: A phase Ib/II, single-arm trial of delivering intravesical therapy for #BladderCancer in patients’ homes. Presentation by @TimLyonMD @MayoClinic. #SUO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/29N692h84t @UroOnc #SUO2025

#TrialsinProgress - ResQ132Ex-NMIBC: Expanded access of recombinant mycobacterium BCG in #NMIBC. Presentation by Neal Shore, MD, FACS @CURCMB. #SUO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/OTWtvUY2Ks @TheSTARTCenter @UroOnc #SUO2025

#TrialsinProgress: Safety and efficacy of belzupacap sarotalocan (AU-011), a virus-like drug conjugate, in participants with nonmuscle-invasive #BladderCancer. Presentation by @MaxKates @HopkinsMedicine. #SUO25 written coverage by @RKSayyid @UAUrology > https://t.co/MokEv1wx3I @UroOnc

#TrialsinProgress - TRIPLE-SWITCH(SWOG/CCTG-PR26): Randomized phase III clinical trial of docetaxel with androgen receptor pathway inhibitors for #mCSPC patients with a suboptimal PSA response. Presentation by @sokolova_md @OHSUNews. #SUO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/3aW9SEfnMf @UroOnc

#TrialsinProgress - CONSOLIdaTE-01: Phase II trial of consolidative surgery following enfortumab vedotin + pembrolizumab in patients with locally advanced/oligometastatic #UrothelialCarcinoma. Presentation by Fady Ghali, MD @Yale_Urology. #SUO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/vCkPuEWKOA @UroOnc

#TrialsinProgress - CT-READ: ctDNA response adapted treatment de-escalation in metastatic #UrothelialCarcinoma. Presentation by @AbdulQadarMD @OUUrology. #SUO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/qmxZDLhlr1 @UroOnc

The Impact of Convictions on Hunter Biden and Donald Trump's Pending Trials
#HunterBidenTrial #DonaldTrumpTrial #ConvictionsImpact #LegalNews #PleaDealAnalysis #CourtCases #JudicialSystem #LegalMatters #TrialsInProgress #HunterBiden
#ASCO24 - Drop by and chat about the #NEO-RT trail now! If you’re at @ASCRS_1 you can talk to @MarkWhitefordMD @drcarl_vancouvr #Trialsinprogress #organsparing #rectalcancer

#Research is #Hope and how we are moving #forward. There are many ongoing #TrialsInProgress presented at #ccfac24.
@MiteshBorad @DrAngelaLamarca
Part 2/2

#Research is #Hope and how we are moving #forward. There are many ongoing #TrialsInProgress presented at #ccfac24. Part 1/2
@MiteshBorad @DrAngelaLamarca

Chandigarh Cricket Trials in full swing! 🏏 Senior Men’s hopefuls showcasing their talent and determination at the trials. Best of luck to all the aspiring cricketers giving it their all! 💪 #UTCA #ChandigarhCricket #TrialsInProgress #SeniorMensCricket

#TrialsinProgress "#MRD assay to evaluate recurrence and response via a tumor-informed assessment: MARIA-Breast observational trial." @aadel_chaudhuri @WUSTLmed #collaboration @Invitae
@ASCO #ASCO23
https://t.co/pOy0ITCn00
#breastcancer #tumorinformed #bespoke #liquidbiopsy #precisionmedicine #precisiontherapy #recurrencemonitoring

Hope you’ll have a chance to come by our poster for #TrialsInProgress at #ASCO23. Our pilot IIT for #lifileucel #TIL cell therapy in patients with #melanoma #brainmetastases is accruing at @MSKCancerCenter and soon @StanfordCancer! Great collaboration with @alexshoushtari! @OncoAlert

8a) Based on the above safety/activity @IASLC #WCLC22 #TrialsinProgress presented by @MLJohnsonMD2 et al. @SarahCannonDocs, WCLC EP08.02-111
➡️SHP2i improved KRASG12C responses #xenograft studies!
➡️SHP2i ⬆️ innate/adaptive #immunity.
(cont)

9) @ASCO #ASCO22 #TrialsinProgress TPS 9148 presented by Govindan et al. @DrMarkAwad @ShirishGadgeel
➡️VS-6766, RAF/MEK clamp 🔼 KRASG12C ➖
#RAMP-203, Phase 1/2 study of combination
🔚✴️R2PD dose for dose expansion studies! @HemOncFellows @KRASKickers
🔓https://t.co/1qkeCEgBNp

8a) @ASCO #ASCO22 #TrialsinProgress presented Arbour et al. @MSKCancerCenter @FSkoulidis @MDAndersonNews
➡️PDL1<1%, STK11m #LCSM outcomes 😧
❓ Role of #Sotorasib
8/10 what about #TrialsInProgress? Abs #TPS623 reports the design of the randomized phase 2 neoadjuvant “TALENT” study of T-DXd +/- anastrozole for HER2-low HR+ EBC.
https://t.co/nSb25dFOuE

For the 1st time this year...#TrialsinProgress for abstracts at #IGCS2022 #IGCSNYC #IAmGoing!
Thank you @GynCancerMD @audreytsunoda for chairing the scientific program committee this year!
Last Seen Hashtags on Sotwe
الجزءالثاني_والأخير
Seen from Saudi Arabia
growthonpurpose
Seen from United States
noida or uttar pradesh
Seen from India
flystoner
Seen from Korea
FinancialSafety
Seen from Colombia
魔力舞社
Seen from Japan
minichat()(*)()(****) filter:videos
Seen from United States
ECLP
Seen from Germany
PABATInUNGA78
bromance
Seen from Germany
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
118.9M followers

Cristiano Ronaldo 
@cristiano
114.6M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90.1M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.5M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.5M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers
























